Susan Hasty, Publisher
Table of Contents . . . January 13th, 2007
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Law Weekly | Other Publications
Cancer Vaccines - Data from University of Pittsburgh, Pittsburgh Cancer Institute advance knowledge in cancer vaccines
Legal Issues - Celgene notified of ANDA filing for thalidomide
Anemia - Abt analysis suggests lower drug cost for Procrit in outpatient setting
Anemia - Affymax presents results from phase II trial of Hematide in anemic cancer patients
Anemia - Data show efficacy of extended dosing of Aranesp in treatment of chemotherapy-induced anemia
Anemia - Phase II data show promise of Aranesp treatment for anemia of cancer
Anemia - Target hemoglobin achieved in study of epoetin alfa in cancer-related anemic patients
Atherosclerosis Therapy - New atherosclerosis therapy study findings recently were published by researchers at Wonkwang University
Awards - Breast cancer foundation names 2006 Komen Brinker award winners for scientific distinction
Breast Cancer - Abraxis BioScience presents data at San Antonio Breast Cancer Symposium
Breast Cancer - Arimidex combined with Herceptin extended progression-free survival in some breast cancer patients
Breast Cancer - Breast cancer guidelines available at Medscape
Breast Cancer - CellSearch System is cleared for monitoring metastatic breast cancer
Breast Cancer - MEABCO's anticancer molecule carrier drug widens field of first-line cytostatic agents
Breast Cancer - National Comprehensive Cancer Network updates breast cancer guidelines
Breast Cancer - Researchers find two biomarkers with the potential to predict breast cancer spread
Breast Cancer Therapy - Hyperthermia therapy for recurrent breast cancer added to 2007 NCCN guidelines
Breast Cancer Therapy - Kosan's Hsp90 inhibitor, tanespimycin, shows promising antitumor activity in breast cancer
Breast Cancer Therapy - Lapatinib to be evaluated internationally as adjuvant therapy in early stage breast cancer
Business & Finance - DiagnoCure announces fiscal 2006 fourth quarter and year-end results, focused strategic direction
Business Update - Cancer patients, survivors exchange critical emotional support
Business Update - Cerep reports on CER227185, achievements with CER233790 and new tumor reversion promoters
Business Update - Crystal Research releases executive report detailing CytoCore Inc. prospects
Business Update - CT laser breast imaging attracts attention at radiological meeting
Business Update - Dana-Farber/Harvard Cancer Center implements Phase Forward's electronic data capture product
Business Update - EDAP strengthens U.K., German sales teams; proven senior professionals added in growth markets
Business Update - MethylGene picks multi-targeted kinase as clinical candidate in cancer tumors, angiogenesis
Cancer Gene Therapy - Data on cancer gene therapy discussed by researchers at Fudan University, Department of Pharmaceutics
Cancer Gene Therapy - Data on cancer gene therapy published by researchers at Central Hospital
Cancer Gene Therapy - Data on cancer gene therapy published by researchers at University of Medicine
Cancer Gene Therapy - Investigators at University of Connecticut, Center for Molecular Medicine zero in on cancer gene therapy
Cancer Gene Therapy - New cancer gene therapy data have been reported by researchers at Southern Illinois University
Cancer Gene Therapy - New cancer gene therapy research from University of Turku outlined
Cancer Gene Therapy - New cancer gene therapy study findings have been reported by researchers at Princess Margaret Hospital
Cancer Gene Therapy - New cancer gene therapy study findings recently were published by researchers at Chinese University of Hong Kong
Cancer Gene Therapy - Research reports from University of California provide new insights into cancer gene therapy
Cancer Gene Therapy - Research results from St. Louis University, Cancer Center update knowledge of cancer gene therapy
Cancer Gene Therapy - Researchers at University of Padua, Department of Pharmaceutical Sciences have published new data on cancer gene therapy
Cancer Gene Therapy - Researchers from Akdeniz University, Faculty of Medicine publish findings in cancer gene therapy
Cancer Gene Therapy - Researchers from Cancer Research UK Center for Cancer Therapeutics describe findings in cancer gene therapy
Cancer Gene Therapy - Researchers from Chang Gung Memorial Hospital, Department of Radiation Oncology discuss findings in cancer gene therapy
Cancer Gene Therapy - Researchers from Oxford University, Department of Clinical Pharmacology describe findings in cancer gene therapy
Cancer Gene Therapy - Researchers from University Hospital, Department of Pathology detail findings in cancer gene therapy
Cancer Gene Therapy - Researchers from Uppsala University, Immunology Division report on findings in cancer gene therapy
Cancer Gene Therapy - Researchers' work from Institute of Biological Research and Biotechnology focuses on cancer gene therapy
Cancer Gene Therapy - Researchers' work from University of Pennsylvania focuses on cancer gene therapy
Cancer Gene Therapy - Scientists at National Institutes of Health target cancer gene therapy
Cancer Gene Therapy - Scientists at Peking Union Medical College describe research in cancer gene therapy
Cancer Gene Therapy - Studies from Ghent University, Center for Medical Genetics have provided new information about cancer gene therapy
Cancer Gene Therapy - Studies in the area of cancer gene therapy reported from Dana-Farber Cancer Institute, Department of Pediatric Oncology
Cancer Research - Certain types of cancer are becoming more common, while rates of others are decreasing
Cancer Research - Data show childhood, youth cancer survival factors vary by race, follow-up care
Cancer Research - Run amok enzyme causes the same problems in both humans and fruit flies
Cancer Therapy - A new gamma camera technique is used for the detection of small breast tumors
Cancer Therapy - Access to prior mammograms improves radiologists' detection of breast cancer
Cancer Therapy - Allergy drug slows pancreatic tumor growth, enhances chemotherapy in preclinical studies
Cancer Therapy - Inex data shows INX-0167 potential for cancer treatment in combination with monoclonal antibodies
Cancer Therapy - Introgen announces new clinical data confirming Advexin survival benefit
Cancer Therapy - Kinase inhibitor induces tumor regression in multiple preclinical models
Cancer Therapy - Neopharm announces efficacy results for Phase III PRECISE trial
Cancer Therapy - New study demonstrates efficacy of Pfizer's Aromasin for early breast cancer
Cancer Therapy - Notch-blocking therapy improves the effects of breast cancer hormonal therapy
Cancer Therapy - One in five early-stage breast cancer patients may not follow hormonal therapy plan
Cancer Therapy - Pair of microRNA molecules controls a major oncogene in most common leukemia
Cancer Therapy - Researchers explain the characteristics of fast growing skin cancers
Cancer Therapy - Use of mammograms in men is rising, but Mayo Clinic researchers find little reason to administer
Cancer Vaccine - Positive phase II clinical trial results with HER2/neu vaccine announced
Cancer Vaccines - Data on cancer vaccines described by researchers at Wakayama Medical University, Department of Surgery
Cancer Vaccines - New data from Ludwig Institute for Cancer Research illuminate research in cancer vaccines
Cancer Vaccines - Recent studies from University of Heidelberg, Department of Internal Medicine IV add new data to cancer vaccines
Cancer Vaccines - Research from Ulleval University in cancer vaccines provides new insights
Cancer Vaccines - Research on cancer vaccines detailed by scientists at Ludwig Institute for Cancer Research
Cancer Vaccines - Research on cancer vaccines reported by scientists at Southern Medical University, Institute of Molecular Immunology
Cancer Vaccines - Researchers from National Institutes of Health describe findings in cancer vaccines
Cancer Vaccines - Scientists at University of Duisburg-Essen detail research in cancer vaccines
Cervical Cancer - Spanish groups' European guidelines recommend HPV DNA testing for cervical cancer screening
Cervical Cancer - U.S. Centers for Disease Control and Prevention recognizes benefit of Digene's HPV DNA test
Clinical Trials - CuraGen and TopoTarget expand belinostat (PXD101) clinical trial in cutaneous T cell lymphoma
Clinical Trials - MGI Pharms, Helsinn report positive phase 3 results in Aloxi injection for post-op nausea
Collaborations - Immunicon and Diagnostic HYBRIDS announce agreement in clinical virology
Collaborations - Merck & Co. and Idera Pharmaceuticals sign collaboration agreement to develop vaccines
Colorectal Cancer - Mount Sinai, EXACT Sciences report publication of data on stool DNA testing for colon cancer
Diet & Nutrition - Reduced dietary fat intake may decrease breast cancer recurrence
Drug Development - Cyclacel submits IND of CYC116, an Aurora kinase and VEGRF2 inhibitor to treat cancer
Drug Development - Peregrine, Biotecnol develop immunocytokine fusion proteins for cancer and anti-viral indications
Drug Development - Seattle Genetics presents advancements in antibody-based drug development programs
Drug Development - Telik announces positive early data showing Telintra enhances production of G-CSF and GM-CSF
Facilities - EpiCept announces relocation of corporate headquarters to Tarrytown, New York
Finance - China Biopharma closes $3 million financing to fuel growth strategies
Gastric Cancer Therapy - Studies from Aichi Cancer Center Research Institute in the area of gastric cancer therapy described
Gastroenterology - Detection of precancerous polyps during colonoscopy related to withdrawal time
Hematology - Avalon Pharmaceuticals announces positive interim results for AVN944 phase I trial
Hematology - New Evoltra data show impressive response and survival rates
Hospitals & Health Networks - India's first Trilogy accelerator ordered for Tata Memorial Hospital in Mumbai
Imaging - Chinese hospitals now permitted to charge for CT laser breast imaging exams
Information Technology - Online portal launched for adolescents and young adults with cancer
Kidney Cancer - Roche's Avastin shows positive outcomes in patients with advanced kidney cancer
Kidney Research - Kidney transplantation is linked with an increased risk of various cancers
Leukemia - Antisoma advancing AS1411 into phase II in leukemia, positive data presented
Leukemia - Ariad presents efficacy data on oral kinase inhibitor for hematologic cancer
Leukemia - Bioenvision announces latest data on Evoltra in pediatric and adult leukemias
Leukemia - ChemGenex reports on Ceflatonin/Gleevec therapy in CML patients resistant to Gleevec alone
Leukemia - Chronic lymphocytic leukemia patients respond to lenalidomide
Leukemia - Dacogen for Injection data presented at hematology conference
Leukemia - Data demonstrate clinical activity of Vidaza with histone deacetylase inhibitors in leukemias
Leukemia - Kosan's Hsp90 inhibitor, alvespimycin, shows antitumor activity in refractory leukemia
Leukemia - M.D. Anderson phase 1/2 study shows multi-kinase inhibitor active against leukemias
Leukemia - MethylGene, Pharmion initiate trial of histone deacetylase inhibitor in myelogenous leukemia
Leukemia - New options treat chronic myeloid leukemia, overcome imatinib resistance
Leukemia - Phase 1 trial of SNS-595 in advanced leukemias demonstrates promising clinical activity
Leukemia - Study shows Sprycel achieved higher cytogenetic responses, longer survival than Gleevec
Leukemia Gene Therapy - Research data from Ecole normale superieure de Lyon update understanding of leukemia gene therapy
Licensing Agreements - Sangamo BioSciences, City of Hope announce agreements to develop treatment for brain cancer
Licensing Agreements - Somanta signs letter of intent to expand sublicense agreement with Virium for phenylbutyrate
Liver Cancer - Positive results announced for liver cancer trial
Lung Cancer - Cell Therapeutics closes PGT305 lung cancer clinical trial, plans new PGT306 protocol
Lung Cancer - Data show Avastin plus chemotherapy improves survival in lung cancer patients
Lung Cancer - Phase II trial of GV1001 in lung cancer started
Lung Cancer - Study harnesses Elekta Technologies to offer hope for lung tumor patients
Lymphoma - Alternatives to standard chemotherapy prolong survival in lymphoma, leukemia patients
Lymphoma - Novacea announces positive AQ4N Phase I study in lymphoma
Lymphoma - Novel protein constructs active against lymphoma in animal models
Market Analysis - Implantable cardioverter defibrillator market rebounding in Q4 2006
Medicare - Early stage colon cancer diagnoses are up since expansion of Medicare coverage
Mergers & Acquisitions - Indevus Pharmaceuticals to acquire Valera Pharmaceuticals
Mergers & Acquisitions - Kiadis and Celmed complete merger to create oncology drug development company
Mergers & Acquisitions - MacroMed announces agreement signed for acquisition by U.K.-based Protherics for $25 million
Multiple Myeloma - AEterna reports positive phase II data on perifosine in refractory multiple myeloma
Multiple Myeloma - CuraGen and TopoTarget present updated PXD101 Phase II multiple myeloma results at ASH
Multiple Myeloma - Cytokinetics announces non-clinical poster presentation regarding ispinesib
Multiple Myeloma - EntreMed presents data on combination of Panzem and Velcade in multiple myeloma
Multiple Myeloma - ImmunoGen presents encouraging HuN901-DM1 findings in multiple myeloma
Multiple Myeloma - Interim analysis: Doxil/Velcade combo prolongs time to progression in refractory MM
Multiple Myeloma - Kosan's lead Hsp90 inhibitor, tanespimycin, shows antitumor activity in multiple myeloma
Multiple Myeloma - Myeloma Foundation reports studies presented at meeting show gains in blood cancers treatment
Multiple Myeloma - Myeloma Foundation researchers identify pathways that mediate side effects from therapy
Myelodysplastic Syndromes - Moffitt researcher reports blood cancer patients treated with Revlimid live longer
Myelodysplastic Syndromes - University of Massachusetts research shows benefits of Revlimid treatment in MDS patients
Myeloma - Addition of thalidomide to myeloma therapies can enhance clinical activity
Nanotechnology - Research results from University of Washington update understanding of nanotechnology
Non-Hodgkin Lymphoma - Cell Therapeutics reports complete remission, durable survival data in Pixantrone trial
Non-Hodgkin Lymphoma - Cell Therapeutics, Inc. announces Pixantrone combination regimen produces high response rates
Non-Hodgkin Lymphoma - Dynavax reports positive Phase 2a NHL data at hematology conference
Non-Hodgkin Lymphoma - New data show low doses of humanized anti-Cd20 antibody active in non-Hodgkin lymphoma
Non-Hodgkin Lymphoma - New York cancer center reports promising results using Revlimid in non-Hodgkin lymphoma
Osteoporosis - Survey shows most Americans lack knowledge of risks regarding bone health
Ovarian Cancer - Clumping protein is linked to the return of ovarian cancer
Ovarian Cancer - Marshall Edwards sets initial trial sites and investigator for phase 3 trial for phenoxodiol
Pain Management - Novel discovery demonstrates how popular class of pain killers can alter various forms of cancer
Pancreatic Cancer - Philadelphia group confirms GenoMed's approach to pancreatic cancer
Patents - Biomarkers for diagnosis, early detection of breast cancer highlight patent filing
Patents - Introgen receives European patent for commercial production of adenovirus
Patents - Marshall Edwards reports U.S. patent advance for anticancer drug candidate phenoxodiol
Patents - ValiRx reports intended grant of GeneICE technology patent by European Patent Office
Personnel - Donald S. Masters, PhD, named new president and CEO of Triton BioSystems, Inc.
Personnel - Dr. Bob Tepper, president of R&D, to leave Millennium
Personnel - Dynavax appoints Dr. David M. Lawrence, Kaiser chairman emeritus, to board of directors
Personnel - Poniard Pharmaceuticals appoints clinical advisory board
Philanthropy - Safeway Inc. funds mobile mammography clinic with $800,000 gift
Prostate Cancer - Bavituximab equivalent plus docetaxel reduces growth of human prostate tumors in mice by 94%
Prostate Cancer - Cougar Biotechnology initiates Phase II trial of abiraterone acetate for prostate cancer
Sarcomas - Keryx begins phase II multicenter study of KRX-0401 for the treatment of rare sarcomas
Squamous Cell Carcinoma Therapy - Investigators at University College, University College of London release new data on squamous cell carcinoma therapy
Stem Cell Research - Cellerant Therapeutics presents positive preclinical data on purified blood-forming stem cells
Stem Cell Research - Theralux ATIR may be feasible strategy for mismatched stem cell transplantation
Tissue Engineering - Findings in tissue engineering reported from Cornell University, Department of Molecular Medicine
Tuberculosis Vaccines - Recent findings in tuberculosis vaccines described by researchers from Centenary Institute of Cancer Medicine and Cell Biology
Tumor Research - MIT implant measures tumor growth and treatment
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.